CHICAGO, IL USA (UroToday.com) - Presented by Bajorin DF,1 Gomella LG,2 Sharma P,3 Plimack ER,4 O’Donnell PH,5 Hoffman-Censits J,2 Flaig TW,6 Quinn DI,7 Campogan D,8 Haynes H,8 McCoy C,8 Maher J,8 DeVries T,8 Sheikh N,8 and Lerner SP9 at the American Society of Clinical Oncology (ASCO) 50th Annual Meeting - May 30 - June 3, 2014 - Chicago, Illinois USA
FREE DAILY AND WEEKLY NEWSLETTERS OFFERED BY CONTENT OF INTEREST
Did you find this article relevant? Subscribe to UroToday-GUOncToday!
The fields of GU Oncology and Urology are advancing rapidly including new treatments, enrolling clinical trials, screening and surveillance recommendations along with updated guidelines. Join us as one of our subscribers who rely on UroToday as their must-read source for the latest news and data on drugs. Sign up today for blogs, video conversations, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.
1Memorial Sloan-Kettering Cancer Center, New York, NY, USA; 2Jefferson Medical College and Kimmel Cancer Center, Philadelphia, PA, USA; 3University of Texas MD Anderson Cancer Center, Houston, TX, USA; 4Fox Chase Cancer Center, Philadelphia, PA, USA; 5The University of Chicago, Chicago, IL, USA; 6University of Colorado, Denver, CO, USA; 7University of Southern California Norris Comprehensive Cancer Center, Los Angeles, CA, USA; 8Dendreon Corporation, Seattle, WA, USA; 9Baylor College of Medicine, The Scott Department of Urology, Houston, TX, USA